Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000461165 | SCV000562880 | likely benign | Long QT syndrome | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618105 | SCV000737421 | likely benign | Cardiovascular phenotype | 2017-07-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001093116 | SCV001866299 | likely benign | not provided | 2018-07-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002481495 | SCV002794842 | likely benign | Timothy syndrome; Brugada syndrome 3; Long qt syndrome 8 | 2021-08-03 | criteria provided, single submitter | clinical testing |